RIZZOLO, PIERA
 Distribuzione geografica
Continente #
NA - Nord America 2.466
EU - Europa 548
AS - Asia 225
SA - Sud America 10
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.256
Nazione #
US - Stati Uniti d'America 2.444
IT - Italia 202
AT - Austria 113
IN - India 95
CN - Cina 78
SE - Svezia 60
SG - Singapore 44
UA - Ucraina 40
FI - Finlandia 38
DE - Germania 21
CA - Canada 20
BG - Bulgaria 16
GB - Regno Unito 15
IE - Irlanda 13
FR - Francia 9
AR - Argentina 8
BE - Belgio 5
RO - Romania 5
NL - Olanda 4
TG - Togo 4
AL - Albania 2
BR - Brasile 2
CH - Svizzera 2
HK - Hong Kong 2
MX - Messico 2
PL - Polonia 2
TR - Turchia 2
AU - Australia 1
ES - Italia 1
EU - Europa 1
IR - Iran 1
KR - Corea 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
SC - Seychelles 1
Totale 3.256
Città #
Fairfield 439
Ashburn 210
Seattle 187
Woodbridge 176
Chandler 168
Houston 166
Cambridge 142
Wilmington 137
Dearborn 126
Vienna 99
Rome 94
Ann Arbor 88
San Paolo di Civitate 59
Princeton 54
Lawrence 42
New York 42
Plano 40
Millbury 30
Beijing 28
San Diego 22
Boston 17
Andover 16
Sofia 16
Ottawa 15
Jacksonville 13
Dublin 12
Nanjing 10
Norwalk 9
Chennai 8
Federal 8
Phoenix 8
Bremen 7
Hefei 7
Kunming 6
San Mateo 6
Des Moines 5
Helsinki 5
Milan 5
Singapore 5
Toronto 5
Bühl 4
Fremont 4
Grafing 4
Lomé 4
London 4
Redmond 4
Brussels 3
Falls Church 3
Jinan 3
Los Angeles 3
Nanchang 3
Naples 3
Pisa 3
Shanghai 3
Washington 3
Alba 2
Bern 2
Buffalo 2
Chengdu 2
Erice 2
Florence 2
Guangzhou 2
Herndon 2
Hong Kong 2
Istanbul 2
Mexico City 2
Napoli 2
Noventa Vicentina 2
Paris 2
Proszowice 2
Southend 2
Waanrode 2
Wandsworth 2
Zhengzhou 2
Americana 1
Amsterdam 1
Ariccia 1
Arnsberg 1
Baotou 1
Boardman 1
Brentford 1
Bristol 1
Changsha 1
Chongqing 1
Civitavecchia 1
Columbus 1
Fuzhou 1
Gloucester 1
Harbin 1
Hebei 1
Hounslow 1
Indiana 1
Jönköping 1
Kashan 1
Laurel 1
Mcallen 1
Monte Azul Paulista 1
Naaldwijk 1
Negrar 1
New Bedfont 1
Totale 2.647
Nome #
449: Gene-specific methylation profiles in male breast cancer 103
CD44 mRNA expression in hormonally treated and non-treated prostate cancer cases 99
BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy 97
962: Association of SULT1A1 Arg213His polymorphism with male breast cancer risk: a case−control study in Italy 94
Insight into genetic susceptibility to male breast cancer by multigene panel testing: results from a multicenter study in Italy 92
Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in Italy 92
Association of SULT1A1 Arg²¹³His polymorphism with male breast cancer risk: results from a multicenter study in Italy. 92
Metastases risk in thin cutaneous melanoma: Prognostic value of clinical-pathologic characteristics and mutation profile 90
Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: Results from a multicenter study in Italy 88
A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in Italy 87
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor 86
730 Analysis of EMSY in Italian Male Breast Cancer Patients 85
HER2-positive male breast cancer: an update. 84
Association between the BRCA2 N372H variant and male breast cancer risk: A population-based case-control study in Tuscany, Central Italy 82
EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations 80
Analysis of BRIP1 in italian male breast cancer patients 80
MiRNAs as potential prognostic biomarkers for metastasis in thin and thick primary cutaneous melanomas 80
PIK3CA c.3140A>G mutation in a patient with suspected Proteus Syndrome: a case report 79
Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness 79
Methylome profiling of BRCA-positive and BRCA-negative MBCs 77
961: Low-penetrance alleles and male breast cancer risk: Results from a multicenter study in Italy 76
Retesting BRCA1/BRCA2 mutation negative male breast cancer patients using next generation sequencing technologies 75
Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers 75
Smoking and FGFR2 rs2981582 variant independently modulate male breast cancer survival: A population-based study in Tuscany, Italy 74
731 Gene Copy Number Alterations in Male Breast Tumors 73
Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival 72
Inherited and acquired alterations in development of breast cancer. 71
Contribution of MUTYH variants to male breast cancer risk: results from a multicenter study in Italy 70
Mutational profiling in melanocytic tumors: multiple somatic mutations and clinical implications. 70
Gene-specific methylation profiles in BRCA-mutation positive and BRCA-mutation negative male breast cancers 69
BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases 61
Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk 61
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of modifiers of BRCA1/2 60
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene 58
DNA repair and metabolic gene polymorphisms and male breast cancer risk 58
Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy 58
SULT1A1 gene deletion in BRCA2-associated male breast cancer: a link between genes and environmental exposures? 57
Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: Results from a collaborative multicenter study in Italy 57
A-1012G Promoter Polymorphism of Vitamin D Receptor Gene Is Associated with Psoriasis Risk and Lower Allele-Specific Expression 56
Gene promoter methylation and DNA repair capacity in monozygotic twins with discordant smoking habits. 55
Role of EGFR, HER2 and PIK3CA alterations in male breast cancer 54
Male breast cancer: genetics, epigenetics, and ethical aspects 53
Mutation screening of RAD51C in male breast cancer patients. 46
The BRCAPRO 5.0 model is a useful tool in genetic counseling and clinical management of male breast cancer cases 45
Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores 44
Proffered papers and posters presented at the Sixth International Symposium on Hereditary Breast and Ovarian Cancer— BRCA: Challenges and Opportunities 42
Breast cancer: not only a "woman's" diseases 36
2008 34
BRCA1/BRCA2 mutation profile and phenotypic features of male breast cancer: a population based in Italy 31
Totale 3.437
Categoria #
all - tutte 8.072
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.072


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019267 0 0 0 0 0 0 0 0 0 0 151 116
2019/20201.101 115 38 14 57 107 204 177 129 111 65 36 48
2020/2021270 32 45 12 9 19 18 5 15 48 39 21 7
2021/2022591 6 32 51 7 65 16 17 51 37 34 169 106
2022/2023633 112 173 74 62 47 52 7 33 47 7 13 6
2023/2024257 14 45 15 14 49 76 3 13 0 28 0 0
Totale 3.437